Study of the clinical data concerning patients suffering from bronchial asthma and analysis of the autopsy data allow the conclusion about the presence of a pathogenetically validated symptomatic arterial hypertension including its drug patterns. The increased number of cases of bronchial asthma and arterial hypertension constellation attests to a considerable unbalance of the autonomous nervous system, alterations of the sympathoadrenal effects in such patients, which makes the clinical picture and course of modern bronchial asthma more complicated. The pathogenetic approach to the treatment of such patients characterized by hypersensitivity to the environmental factors, stress situations and to drugs which stimulate the sympathoadrenal system will permit one to avoid diagnostic, deontological errors, to choose sound therapy including measures aimed at preventing arterial hypertension itself.